$80.47
4.97%
Nasdaq, Oct 20, 01:44 pm EDT. Market open.
Why the stock moved Why the stock moved Beta
ISIN
US2561631068
Symbol
DOCU

Docusign Stock price

$76.66
+8.09 11.80% 1M
+28.95 60.68% 6M
+8.26 12.08% YTD
+5.98 8.46% 1Y
+35.52 86.34% 3Y
-196.23 71.91% 5Y
+36.93 92.95% 10Y
+36.93 92.95% 20Y
Nasdaq, Closing price Mon, Oct 19 2026
+2.01 2.69%
ISIN
US2561631068
Symbol
DOCU
Industry

AI Insights on Docusign Insights AI Insights on Docusign

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Is Docusign a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,109 stocks worldwide.

Key metrics

Basic
Market capitalization
$14.3b
Enterprise Value
$13.6b
Net debt
-
Cash
$777.7m
Shares outstanding
191.0m
Valuation
P/E
45.1
P/S | estimate
4.3 | 4.0
EV/Sales | estimate
4.0 | 3.8
EV/FCF | ex SBC
11.3 | 22.9
P/B
8.3
Financial Health
Equity Ratio
45.3%
Return on Equity
16.1%
ROCE
20.2%
ROIC
19.0%
Debt/Equity
-
Share-Based Compensation & Dilution
SBC | % of Revenue
$606.2m | 18.0%
SBC as % of FCF
50.6%
SBC Growth 1Y
-0.5%
Share Count Growth 1Y
-5.0%
Shareholder Yield
5.0%
Financials
Revenue | estimate
$3.4b | $3.6b
EBITDA
$524.9m
EBIT
$402.0m
Net Income
$329.9m
Free Cash Flow | ex SBC
$1.2b | $592.1m
Growth
Revenue | estimate
8.6% | 11.0%
EBITDA
45.7%
EBIT
64.4%
Net Income
17.4%
Free Cash Flow
28.1%
Margin
Gross
79.5%
EBITDA
15.6%
EBIT
12.0%
Net
9.8%
Free Cash Flow | ex SBC
35.7% | 17.6%
More
EPS
$1.7
FCF per Share
$6.3
Short interest
8.1%
Employees
7k
Rev per Employee
$460.0k

Docusign Stock Analysis

Unlock Scores for Free

Analyst Opinions

29 Analysts have issued a Docusign forecast:

10x Buy
34%
18x Hold
62%
1x Sell
3%

Analyst Opinions

29 Analysts have issued a Docusign forecast:

Buy
34%
Hold
62%
Sell
3%

Docusign Events

Past Events
SEP
3
Q2 2027 Earnings Call
about 2 months ago
JUN
4
Q1 2027 Earnings Call
5 months ago
MAR
17
Q4 2026 Earnings Call
7 months ago
DEC
9
53rd Annual Nasdaq Investor Conference
10 months ago
DEC
4
Q3 2026 Earnings Call
11 months ago

Financial data from Docusign

Jul '26
+/-
%
3,361 3,361
9% 9%
100%
- Direct Costs 689 689
8% 8%
21%
2,672 2,672
9% 9%
79%
- Selling and Administrative Expenses 1,611 1,611
3% 3%
48%
- Research and Development Expense 659 659
4% 4%
20%
525 525
46% 46%
16%
- Depreciation and Amortization 123 123
6% 6%
4%
EBIT (Operating Income) EBIT 402 402
64% 64%
12%
Net Profit 330 330
17% 17%
10%

In millions USD.

Don't miss a Thing! We will send you all news about Docusign directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Docusign Stock News

Neutral
PRNewsWire
●
about 7 hours ago
The annual list recognizes B2B companies that provide essential services and expertise to help entrepreneurs and businesses grow. SAN FRANCISCO, Oct. 20, 2026 /PRNewswire/ -- Docusign (Nasdaq: DOCU) today announced it has been named a 2026 Inc. Power Partner Awards winner for the second year in a row, recognizing the company among the leading B2B partners supporting entrepreneurs and businesses...
Neutral
PRNewsWire
●
7 days ago
Docusign expands its Salesforce partnership, making its IAM platform natively available to all AI agents across Salesforce and Slack SAN FRANCISCO, Oct. 13, 2026 /PRNewswire/ -- Docusign (Nasdaq: DOCU) today announced the next chapter in its more than 20-year partnership with Salesforce (NYSE: CRM). The expanded partnership brings the Docusign Intelligent Agreement Management (IAM) platform nat...
Neutral
Market Watch
●
8 days ago
As more money flows toward AI software offerings, Salesforce could deepen its customer relationships while Adobe looks vulnerable, analysts say.
More Docusign News

Company Profile

Docusign, Inc. engages in the provision of cloud-based electronic signature solutions, which helps companies and individuals securely collect information, automate data workflows, and sign anything. The firm automates manual and paper-based processes allowing users to manage all aspects of documented business transactions including identity management, authentication, digital signature, forms and data collection, collaboration, workflow automation, and storage. Its products include eSignature, CLM, Gen for Salesforce, Document Generation, Standards-Based Signatures, Notary and Web Forms. The company was founded by Thomas H. Gonser and Court Lorenzini in 2003 and is headquartered in San Francisco, CA.

Head office United States
CEO Mr. Thygesen
Employees 7,044
Founded 2003
Website www.docusign.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today